8 min read

Analyst Hints & Ratings — November 17, 2026 — Midday Update — Last 24 Hours (Pacific Time)

Stifel initiated coverage on 20+ retail names while Mizuho launched alternative asset manager coverage, driving broad analyst optimism. AI demand fueled bullish calls on Meta (UBS Buy, $815 PT), Amazon (UBS Buy, $340 PT), and Cisco (HSBC upgrade to Buy), though Nvidia faced rare divergence as Lynx E

Executive Summary

Analyst activity over the past 24 hours skews broadly bullish, with price target raises and initiations outnumbering cuts, though a meaningful wave of downgrades adds nuance. Stifel dominated the session with a sweeping retail sector initiation covering 20+ names, while Mizuho launched a comprehensive alternative asset manager coverage universe. Key themes driving action include AI demand (Meta, Amazon, Cisco, Nvidia), beef margin recovery (Tyson Foods), healthcare sector repricing (Humana, Medtronic, CG Oncology), and leadership uncertainty at Nvidia creating a rare analyst divergence.


Analyst Action Breakdown

Action Type Count Percentage
Upgrades 12 ~6%
Downgrades 14 ~7%
PT Raises 55 ~28%
PT Cuts 35 ~18%
Reiterations 48 ~24%
Initiations 34 ~17%

Net Sentiment: Mildly Bullish — PT raises outnumber cuts by a wide margin, and initiations lean heavily bullish (Buy-rated initiations dominate, particularly from Stifel's retail sweep and Mizuho's asset manager coverage). However, the 14 downgrades — including notable calls on PepsiCo, Tyson, Stanley Black & Decker, and Shoals Technologies — temper the overall tone.


Top Analyst Calls

🟢 UBS → Meta Platforms (META) — Initiates Buy, PT $815

  • Rationale: UBS assumes coverage citing AI momentum as the core growth driver.

🟢 UBS → Amazon (AMZN) — Initiates Buy, PT $340

  • Rationale: AI outlook underpins the fresh coverage initiation.

🟡 UBS → Alphabet (GOOG) — Assumes Coverage, Neutral, PT $320

  • Rationale: UBS takes a more cautious stance on Alphabet relative to its Big Tech peers.

🟢 HSBC → Cisco (CSCO) — Upgrades to Buy from Hold, PT $133 from $120

  • Rationale: AI networking growth outlook drives the upgrade.

🟢 Morgan Stanley → Nucor (NUE) — Upgrades to Overweight from Equalweight, PT $310

  • Rationale: Capital spending outlook supports the bullish shift on the steel producer.

🔴 Bernstein → PepsiCo (PEP) — Downgrades to Underperform from Market Perform, PT lowered

  • Rationale: North America business concerns prompt a rare bearish call on the consumer staples giant.

🔴 Lynx Equity → Nvidia (NVDA) — Cuts PT to $135 from $250

  • Rationale: Leadership uncertainty and expectations around an interim CEO drive the steep target reduction.

🟢 Wedbush (Dan Ives) → Nvidia (NVDA) — Reiterates Outperform, PT $225

  • Rationale: Ives holds firm amid the CEO transition, creating a notable divergence with Lynx Equity.

🟢 Bernstein → Humana (HUM) — Raises PT to $515 from $425, maintains Outperform

  • Rationale: Medicare Advantage strength drives the significant $90 target increase.

🟢 TD Cowen → Coca-Cola (KO) — Raises PT to $112 from $104, maintains Buy

  • Rationale: Growth outlook supports the target lift on the beverage giant.

🔴 Cantor Fitzgerald → SharonAI (SHAZ) — Cuts PT to $45 from $109

  • Rationale: Capacity delays trigger a dramatic 59% price target reduction.

🟢 Piper Sandler → Medtronic (MDT) — Upgrades to Overweight from Neutral, PT raised

  • Rationale: Growth outlook improvement drives the upgrade, echoed by TD Cowen's $110 reiteration on FDA clearance.

🔴 TD Cowen → Advantage Oil & Gas (AAV) — Downgrades to Sell from Buy

  • Rationale: Acquisition concerns prompt a full two-notch downgrade to Sell.

🟢 JPMorgan → Moderna (MRNA) — Raises PT to $102 from $77, maintains Underweight

  • Rationale: Improved expense outlook drives the $25 target raise even as the firm keeps a bearish rating — a notable divergence.

🟢 Bernstein → Centene (CNC) — Raises PT to $90 from $79, maintains Outperform

  • Rationale: Medicaid outlook improvement supports the target increase.

Firm Activity Summary

Stifel — 22+ calls (12 bullish, 10 neutral/hold)

  • Initiated: Walmart (Buy), Costco (Buy), Kroger (Buy), Carvana (Buy), Dollar Tree (Buy), Casey's (Buy), O'Reilly (Buy), SharkNinja (Buy), Williams-Sonoma (Buy), Dollar General (Hold), Target (Hold), Best Buy (Hold), BJ's Wholesale (Hold), Wayfair (Hold), CarMax (Hold), AutoZone (Hold), Advance Auto Parts (Hold), Genuine Parts (Hold), Chewy (Hold), Five Below (Hold), Tractor Supply (Hold), Albertsons (Hold), Sprouts (Hold), Murphy USA (Hold)
  • Also raised VF Corp. PT to $19 from $17 (Hold)

Mizuho — 12+ calls (9 bullish, 2 neutral, 1 bearish)

  • Initiated: Blackstone (Outperform), BlackRock (Outperform), KKR (Outperform), Ares Management (Outperform), Apollo Global (Outperform), Blue Owl Capital (Outperform), Invesco (Outperform), Franklin Resources (Neutral), TPG (Neutral), T. Rowe Price (Underperform)
  • Raised: Costco PT to $1,150; Five Below PT to $300; Nextpower PT to $104
  • Downgraded: Stanley Black & Decker to Neutral; cut Diamondback Energy PT to $248
  • Reiterated: Robinhood (Outperform); Neumora (Outperform)

Wells Fargo — 9 calls (7 bullish, 2 neutral)

  • Raised: Cardinal Health PT to $321; Cencora PT to $400; GXO Logistics PT to $75; Church & Dwight PT to $125; Pennant Group PT to $49; Intuit PT to $330
  • Upgraded: Zimmer Biomet to Overweight; Praxis Precision Medicines to Overweight

Truist Securities — 9 calls (8 bullish, 0 bearish)

  • Reiterated Buy: Viking Holdings ($98), OneWater Marine ($12), Home Depot ($373), Nextpower ($145), Biote ($4)
  • Raised PT: Bill.com to $58; CG Oncology to $100; Diamondback Energy to $242
  • Lowered PT: Affirm to $86 (maintains Buy)

Jefferies — 10 calls (6 bullish, 3 hold, 1 downgrade)

  • Buy reiterations: Ardelyx ($8), Ascendis Pharma ($300), Amer Sports ($42), Immatics ($15), BeOne Medicines ($470), iQIYI (cut PT to $1.19)
  • Hold reiterations: Elbit Systems ($790), Incyte ($115), Illumina ($235)
  • Downgraded: IDACORP to Hold from Buy
  • Initiated: Lycia Therapeutics (Buy, $50)
  • Raised: Tencent Music PT to $13.30; lowered New Jersey Resources PT to $54

BMO Capital — 5 calls (2 bullish, 3 neutral)

  • Raised: Tyson Foods PT to $75; Victoria's Secret PT to $100; Equifax PT to $186
  • Cut: Nextpower PT to $108
  • Reiterated: Intuitive Surgical (Outperform, $518)

BTIG — 7 calls (6 bullish, 1 neutral)

  • Raised: VF Corp. PT to $24; Philip Morris PT to $225
  • Reiterated Buy: Spire ($102), Cars.com ($16), Oric Pharmaceuticals ($26), Northrop Grumman ($815)
  • Lowered PT: Redwood Trust to $4.50 (Buy); Turning Point Brands to $101 (Buy); Ispire Technology to $2.90 (Buy)

TD Cowen — 8 calls (5 bullish, 1 neutral, 1 sell)

  • Raised: Kiniksa PT to $115; Coca-Cola PT to $112
  • Lowered: Elastic PT to $85
  • Reiterated Buy: Diageo ($120), Home Depot ($410), Medtronic ($110)
  • Upgraded: Rogers Communications to top pick
  • Downgraded: Advantage Oil & Gas to Sell
  • Initiated: Lycia Therapeutics (Buy)

B.Riley — 6 calls (4 bullish, 2 neutral)

  • Reiterated Buy: LuxExperience ($13), SharonAI ($78), enCore Energy (Buy, cut PT to $1.75)
  • Cut PT: Lumentum to $659; AXT to $43; AirJoule to $6

Raymond James — 7 calls (4 bullish, 2 neutral, 1 market perform)

  • Strong Buy reiterations: Equinix ($250), Aktis Oncology ($40)
  • Outperform reiterations: Flex ($150), Plexus ($275), Sally Beauty ($23)
  • Cut PT: Standard Lithium to $4.75; Ballard Power (Market Perform, PT lowered)

Cantor Fitzgerald — 5 calls (3 bullish, 1 bearish)

  • Raised: Rubrik PT to $125; Cypherpunk PT raised
  • Cut PT: SharonAI to $45 from $109; Duos Technologies to $15
  • Reiterated Overweight: SpaceX ($345)

Bernstein SocGen — 7 calls (3 bullish, 2 neutral, 1 bearish)

  • Raised PT: Humana to $515; Centene to $90; Tyson to $72
  • Reiterated: Chipotle (Outperform, $43); Diamondback Energy (Market Perform, $192)
  • Downgraded: PepsiCo to Underperform; lowered XPeng PT to $15

RBC Capital — 6 calls (2 bullish, 2 neutral, 2 bearish)

  • Raised: Blackstone Digital Infrastructure PT to $26
  • Reiterated Outperform: Eli Lilly ($1,600)
  • Lowered PT: Community Health to $3; PicPay to $9; Advantage Oil & Gas to Cdn$13.50
  • Downgraded: CG Oncology to Sector Perform

H.C. Wainwright — 4 calls (all bullish)

  • Reiterated Buy: Aclaris ($16), Faeth Therapeutics ($60), Alpha Tau Medical ($16), Revolution Medicines ($350)

Guggenheim — 5 calls (3 bullish, 1 neutral, 1 bearish)

  • Initiated: Lycia Therapeutics (Buy)
  • Reiterated Buy: Sysco ($90), Wayfair ($135)
  • Reiterated Neutral: Palo Alto Networks
  • Cut PT: Neumora to $8 from $14 (maintains Buy)

JPMorgan — 4 calls (1 bullish, 2 neutral, 1 downgrade)

  • Raised PT: Moderna to $102 (Underweight); CG Oncology to $113 (Overweight)
  • Resumed: Kimberly-Clark (Neutral, $113)
  • Downgraded: Tyson Foods to Neutral

Piper Sandler — 5 calls (2 bullish, 2 neutral, 1 bearish)

  • Upgraded: Medtronic to Overweight
  • Raised PT: Tyson to $72
  • Cut PT: Connect Biopharma to $5; Jasper Therapeutics to $44
  • Reiterated Neutral: Workday ($190)

UBS — 3 calls (2 bullish, 1 neutral)

  • Initiated/Assumed: Meta (Buy, $815), Amazon (Buy, $340), Alphabet (Neutral, $320)
  • Downgraded: Shoals Technologies to Neutral

Technology & AI is the standout bullish theme. UBS's simultaneous initiation of Meta (Buy) and Amazon (Buy) while taking a more cautious Neutral on Alphabet signals a preference for AI monetization leaders over search-dependent models. HSBC's upgrade of Cisco to Buy on AI networking growth and Wedbush's defense of Nvidia amid CEO transition uncertainty reinforce the view that AI infrastructure spending remains a dominant analyst conviction. The lone bearish outlier — Lynx Equity's dramatic Nvidia PT cut to $135 from $250 — stands in sharp contrast to the broader tech-bullish consensus.

Healthcare saw significant activity across multiple sub-sectors. Medtronic received a notable upgrade from Piper Sandler and a Buy reiteration from TD Cowen on FDA clearance, suggesting improving sentiment on med-tech. Humana and Centene both received meaningful PT raises from Bernstein on Medicare Advantage and Medicaid strength respectively, while CG Oncology saw mixed signals — JPMorgan raised its PT to $113 while RBC downgraded to Sector Perform, and Truist raised its target to $100. The oncology space broadly attracted bullish reiterations across multiple names (Ascendis, BeOne Medicines, Aktis, Revolution Medicines).

Retail was dominated by Stifel's sweeping sector initiation, which leaned cautious-to-neutral overall — the firm initiated more names at Hold than Buy. Bullish picks included Walmart, Costco, Kroger, Carvana, Dollar Tree, and O'Reilly, while Target, Best Buy, Wayfair, Five Below, and Dollar General received Hold ratings. Consumer staples saw a notable bearish call with Bernstein's PepsiCo downgrade to Underperform. Energy was mixed, with Diamondback Energy receiving a PT raise from Truist but cuts from Mizuho and Bernstein's Market Perform reiteration following an acquisition. TD Cowen's double-downgrade of Advantage Oil & Gas to Sell was the starkest bearish energy call of the session.


Market Implications

The session's most significant signal for investors is the broad AI infrastructure consensus forming around Meta, Amazon, and Cisco — three simultaneous bullish calls from major firms in a single session suggests institutional conviction is building around the AI monetization theme heading into year-end. The Nvidia divergence (Wedbush at $225 vs. Lynx Equity at $135) is worth watching closely: leadership transitions at mega-cap tech names historically create short-term volatility, and the $90 gap between these two targets reflects genuine uncertainty about execution risk.

Healthcare is quietly becoming a consensus overweight. The combination of Medtronic's upgrade, Humana's $90 PT raise, Centene's Medicaid tailwind call, and multiple oncology reiterations paints a picture of analysts rotating toward defensive-growth healthcare names. The PepsiCo downgrade to Underperform by Bernstein is a meaningful contrarian signal in consumer staples — if North America volumes continue to disappoint, it could signal broader pressure on the sector.

The Tyson Foods story illustrates analyst divergence at its most visible: JPMorgan downgraded to Neutral on valuation while BMO, Bernstein, and Piper Sandler all raised price targets on beef margin recovery. This kind of split — where the stock has already run and some analysts are taking chips off the table while others see fundamental improvement — is a classic signal that a stock is approaching a near-term ceiling even if the long-term thesis remains intact.


Key Takeaways

  • 🟢 Meta (META) — UBS initiates at Buy with $815 PT, making it one of the highest-conviction Big Tech calls of the session on AI momentum.
  • 🟢 Amazon (AMZN) — UBS Buy initiation at $340 reinforces AI cloud/infrastructure as a core investment theme.
  • 🔴 Nvidia (NVDA) — Lynx Equity's PT cut to $135 from $250 is the most dramatic single target reduction of the day, driven by CEO transition uncertainty; Wedbush's $225 Outperform reiteration creates a stark divergence.
  • 🟢 Cisco (CSCO) — HSBC upgrades to Buy from Hold with PT raised to $133, citing AI networking as a structural growth driver.
  • 🟢 Humana (HUM) — Bernstein raises PT by $90 to $515 on Medicare Advantage strength — one of the largest dollar-value PT increases in the session.
  • 🔴 PepsiCo (PEP) — Bernstein downgrades to Underperform, a rare bearish call on a Dow component citing North America weakness.
  • 🔴 SharonAI (SHAZ) — Cantor Fitzgerald slashes PT to $45 from $109 on capacity delays; B.Riley holds firm at $78 Buy — a significant divergence on a high-risk name.
  • 🟢 Medtronic (MDT) — Piper Sandler upgrades to Overweight and TD Cowen reiterates Buy at $110 on FDA clearance; growing bullish consensus on med-tech recovery.
  • 🟢 Nucor (NUE) — Morgan Stanley upgrades to Overweight from Equalweight with PT raised to $310 on capital spending outlook.
  • 🔴 Advantage Oil & Gas (AAV) — TD Cowen downgrades all the way to Sell from Buy following an acquisition; RBC also cuts PT.
  • 🟢 Coca-Cola (KO) — TD Cowen raises PT to $112 from $104 and names it a Buy; defensive growth names attracting fresh upside.
  • 🔴 Tyson Foods (TSN) — JPMorgan downgrades to Neutral on valuation even as BMO, Bernstein, and Piper Sandler all raise targets — classic post-run divergence.
  • 🟢 Stifel Retail Sweep — 20+ retail initiations in one session; bullish on Walmart, Costco, Kroger, Carvana, O'Reilly, Dollar Tree; cautious on Target, Best Buy, Five Below.
  • 🟢 Mizuho Alt Asset Manager Sweep — Outperform initiations on Blackstone, BlackRock, KKR, Ares, Apollo, Blue Owl; Underperform on T. Rowe Price signals active-vs-passive divergence.
  • 🔴 Lightwave Logic (LWLG) — Freedom Broker cuts PT to $6 from $10, a 40% reduction, on delayed production timeline.
  • 🟢 CG Oncology (CGON) — JPMorgan raises PT to $113 and Truist raises to $100, but RBC downgrades to Sector Perform — regulatory path uncertainty creates a split verdict.
  • 🟢 Blackstone Digital Infrastructure (BXDC) — Both RBC and Deutsche Bank raise PT to $26 on a major deal (Amazon-linked), rare same-day consensus PT raise from two firms.
  • 🔴 Red Cat Holdings (RCAT) — Needham cuts PT to $5 from $15, a 67% reduction, on weak results — one of the steepest percentage cuts of the session.
  • 🟢 Lycia Therapeutics (LYCA) — Triple initiation in one day: Jefferies (Buy, $50), Evercore ISI (Outperform), TD Cowen (Buy), and Guggenheim (Buy) — unusually strong coordinated bullish launch.
  • 🔴 iQIYI (IQ) — Both US Tiger Securities and Jefferies cut price targets (to $0.80 and $1.19 respectively) on revenue decline and content costs.

Independent, data-driven signals.
No hype. No promotions. Just experimental market research from EverHint.

👉 This is not financial advice. Market conditions change rapidly.
Do your own due diligence.
See https://www.everhint.com/disclaimer/ and https://www.everhint.com/faqs/